Semaglutide requires weekly injections and often causes gastrointestinal side effects, while AOD-9604 is generally well-tolerated with minimal digestive impact
GHKCu influences signaling related to oxidative stress and inflammation, supporting pathways that protect tissues from damage and may reduce inflammatory cytokine responses in research contexts, making it relevant for studies on aging and recovery
Human trials remain limited, so much of the discussion comes from preclinical research, clinician experience, and user reports
Conclusions The currently available evidence on the mechanisms of action and clinical effects of GLP-1/GIP dual agonism supports very optimistic prospects for the future use of tirzepatide
But here's the thing they buried it deep
It also plays a big role in liver detoxification, helping the body flush out alcohol, heavy metals, and toxins from the environment